Edge Therapeutics (Series C)

Funding Details
Awarder
Inbox
Date Award
April 09, 2015
Vertical
Biotechnology
Funding URL
View Funding Page
Funding Amount:
$72,500,000

Company Info
Founders
Brian Leuthner
Company Description
Edge Therapeutics, a biotechnology company, transforms FDA-approved drugs into therapies that address unmet acute neurological conditions.
Market
Acute neurological conditions
Location
Berkeley Heights, New Jersey, USA
Coinvestors
BioMed Ventures, Franklin Advisers, Janus Capital, New Leaf Venture Partners, Sofinnova Ventures, Venrock

Links